Hykes Andrew's Form 4 filing
Inari Medical, Inc. (NARI) · filed May 4, 2022
- Accession no.
- 0001562180-22-003739
- Filed
- May 4, 2022
- Trade date
- May 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $398.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hykes AndrewCIK 0001806431 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Common Stock | SSaleDisposed | −200 | $77.14F2 | −$15,428 | 155,366 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −1,418 | $78.76F3 | −$111,681.68 | 155,566 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −2,119 | $79.80F4 | −$169,096.2 | 153,247 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −1,163 | $80.80F5 | −$93,970.4 | 152,084 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −100 | $81.75 | −$8,175 | 151,984 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $77.11 to $77.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $78.36 to $79.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $79.36 to $80.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $80.43 to $81.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.